Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03191461 · ClinicalTrials.gov registry record
Myocardial Perfusion and Fibrosis in Cancer Survivors
A clinical trial, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- 7
- Enrollment target
NCT03191461 is a clinical trial that has completed, run by Virginia Commonwealth University. The registered enrollment target is 7 participants.
The verdict
NCT03191461 has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- 7 participants
- Enrollment target
Study Summary
This is a cross-sectional pilot study. The investigators seek to obtain early information pertaining to the relationship between measurements of myocardial perfusion reserve and myocardial fibrosis after receipt of Anthracycline-based chemotherapy (≥2 years prior).
Interventions
- DIAGNOSTIC_TEST Adenosine stress test MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2017-11-13 |
| Est. Completion | 2024-04-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03191461
The ClinicalTrials.gov registry entry for NCT03191461 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Adenosine stress test MRI is the first listed.
NCT03191461 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03191461 about?
NCT03191461 is a clinical study titled "Myocardial Perfusion and Fibrosis in Cancer Survivors". This is a cross-sectional pilot study. The investigators seek to obtain early information pertaining to the relationship between measurements of myocardial perfusion reserve and myocardial fibrosis after receipt of Anthracycline-based chemotherapy (≥2 years prior).
What is the current status of trial NCT03191461?
This trial is currently completed. The enrollment target is 7 participants. The study started on 2017-11-13. Estimated completion is 2024-04-11.
What interventions are being tested in trial NCT03191461?
The interventions under investigation include: Adenosine stress test MRI (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03191461?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.